

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.52534658 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 6.42865568 |
| 3 | retinal cone cell development (GO:0046549) | 6.03112852 |
| 4 | retinal rod cell development (GO:0046548) | 5.69668507 |
| 5 | photoreceptor cell maintenance (GO:0045494) | 5.62360108 |
| 6 | photoreceptor cell development (GO:0042461) | 5.51352608 |
| 7 | eye photoreceptor cell development (GO:0042462) | 5.32077238 |
| 8 | detection of light stimulus involved in visual perception (GO:0050908) | 5.04278579 |
| 9 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.04278579 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.67135444 |
| 11 | phototransduction (GO:0007602) | 4.07140727 |
| 12 | protein-chromophore linkage (GO:0018298) | 4.00886274 |
| 13 | detection of visible light (GO:0009584) | 3.99161597 |
| 14 | phototransduction, visible light (GO:0007603) | 3.97765069 |
| 15 | detection of light stimulus (GO:0009583) | 3.97698803 |
| 16 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.87695553 |
| 17 | gonadal mesoderm development (GO:0007506) | 3.86934710 |
| 18 | visual perception (GO:0007601) | 3.82115401 |
| 19 | sensory perception of light stimulus (GO:0050953) | 3.79254106 |
| 20 | paraxial mesoderm development (GO:0048339) | 3.71008877 |
| 21 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.69340390 |
| 22 | protein localization to synapse (GO:0035418) | 3.63961822 |
| 23 | photoreceptor cell differentiation (GO:0046530) | 3.58554825 |
| 24 | eye photoreceptor cell differentiation (GO:0001754) | 3.58554825 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55312450 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.52068046 |
| 27 | glutamate secretion (GO:0014047) | 3.51705599 |
| 28 | response to pheromone (GO:0019236) | 3.50435129 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.41984319 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.36976455 |
| 31 | * regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.33703165 |
| 32 | retina development in camera-type eye (GO:0060041) | 3.19952666 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19718115 |
| 34 | * synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.18998572 |
| 35 | GMP metabolic process (GO:0046037) | 3.17344775 |
| 36 | potassium ion homeostasis (GO:0055075) | 3.10781876 |
| 37 | vocalization behavior (GO:0071625) | 3.07828232 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.07649846 |
| 39 | surfactant homeostasis (GO:0043129) | 3.04317454 |
| 40 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.04207060 |
| 41 | cellular response to light stimulus (GO:0071482) | 2.97559020 |
| 42 | chemical homeostasis within a tissue (GO:0048875) | 2.95672029 |
| 43 | detection of external stimulus (GO:0009581) | 2.94789123 |
| 44 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.94420406 |
| 45 | cell communication by electrical coupling (GO:0010644) | 2.92841335 |
| 46 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.91681472 |
| 47 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.90854929 |
| 48 | sodium ion export (GO:0071436) | 2.89958544 |
| 49 | detection of abiotic stimulus (GO:0009582) | 2.88505369 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 2.87503505 |
| 51 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.87392440 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 2.75606838 |
| 53 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75426959 |
| 54 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.73433627 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.73348125 |
| 56 | behavioral response to ethanol (GO:0048149) | 2.72643411 |
| 57 | apical protein localization (GO:0045176) | 2.71661147 |
| 58 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.70878574 |
| 59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.69965184 |
| 60 | protein targeting to Golgi (GO:0000042) | 2.67600772 |
| 61 | regulation of guanylate cyclase activity (GO:0031282) | 2.67556607 |
| 62 | * regulation of synaptic vesicle exocytosis (GO:2000300) | 2.64499276 |
| 63 | phosphorelay signal transduction system (GO:0000160) | 2.62097798 |
| 64 | locomotory exploration behavior (GO:0035641) | 2.59892498 |
| 65 | nonmotile primary cilium assembly (GO:0035058) | 2.58202655 |
| 66 | chemosensory behavior (GO:0007635) | 2.57494919 |
| 67 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.56970567 |
| 68 | establishment of protein localization to Golgi (GO:0072600) | 2.56216323 |
| 69 | * membrane hyperpolarization (GO:0060081) | 2.55660453 |
| 70 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55248272 |
| 71 | membrane repolarization (GO:0086009) | 2.54904493 |
| 72 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.54794610 |
| 73 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51849136 |
| 74 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.51098592 |
| 75 | response to histamine (GO:0034776) | 2.50438889 |
| 76 | membrane repolarization during action potential (GO:0086011) | 2.49693986 |
| 77 | camera-type eye morphogenesis (GO:0048593) | 2.49223669 |
| 78 | neurotransmitter secretion (GO:0007269) | 2.48993195 |
| 79 | neuron cell-cell adhesion (GO:0007158) | 2.48321941 |
| 80 | * innervation (GO:0060384) | 2.48311899 |
| 81 | establishment of nucleus localization (GO:0040023) | 2.47711037 |
| 82 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.47421581 |
| 83 | axon extension involved in axon guidance (GO:0048846) | 2.47421581 |
| 84 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.46720812 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.45753417 |
| 86 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.44223196 |
| 87 | axonal fasciculation (GO:0007413) | 2.43909136 |
| 88 | neuron recognition (GO:0008038) | 2.42080521 |
| 89 | cardiac myofibril assembly (GO:0055003) | 2.38149448 |
| 90 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.37272185 |
| 91 | cell communication involved in cardiac conduction (GO:0086065) | 2.36713993 |
| 92 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.36472693 |
| 93 | positive regulation of vesicle fusion (GO:0031340) | 2.36376090 |
| 94 | * regulation of synaptic vesicle transport (GO:1902803) | 2.36059390 |
| 95 | nucleus localization (GO:0051647) | 2.35415414 |
| 96 | retina layer formation (GO:0010842) | 2.34351960 |
| 97 | carnitine shuttle (GO:0006853) | 2.34254991 |
| 98 | regulation of cGMP metabolic process (GO:0030823) | 2.34132529 |
| 99 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.33603632 |
| 100 | urinary tract smooth muscle contraction (GO:0014848) | 2.33523686 |
| 101 | cochlea development (GO:0090102) | 2.32941272 |
| 102 | notochord development (GO:0030903) | 2.32409741 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.32010368 |
| 104 | synapse assembly (GO:0007416) | 2.31869265 |
| 105 | peripheral nervous system axon ensheathment (GO:0032292) | 2.31230305 |
| 106 | myelination in peripheral nervous system (GO:0022011) | 2.31230305 |
| 107 | epithelial cell-cell adhesion (GO:0090136) | 2.31226195 |
| 108 | startle response (GO:0001964) | 2.29126008 |
| 109 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.28902933 |
| 110 | receptor recycling (GO:0001881) | 2.28570505 |
| 111 | calcium ion import (GO:0070509) | 2.28504045 |
| 112 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.28081875 |
| 113 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.27523113 |
| 114 | ovulation cycle (GO:0042698) | 2.27294777 |
| 115 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.26538034 |
| 116 | stress granule assembly (GO:0034063) | 2.26089386 |
| 117 | asymmetric protein localization (GO:0008105) | 2.25847100 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.25443433 |
| 119 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.25305297 |
| 120 | myofibril assembly (GO:0030239) | 2.24854545 |
| 121 | plasma membrane repair (GO:0001778) | 2.24475873 |
| 122 | myoblast fusion (GO:0007520) | 2.22419022 |
| 123 | biotin metabolic process (GO:0006768) | 2.21994534 |
| 124 | hippo signaling (GO:0035329) | 2.20585938 |
| 125 | embryonic foregut morphogenesis (GO:0048617) | 2.19895334 |
| 126 | macroautophagy (GO:0016236) | 2.18730249 |
| 127 | actin-myosin filament sliding (GO:0033275) | 2.18238227 |
| 128 | muscle filament sliding (GO:0030049) | 2.18238227 |
| 129 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.16678061 |
| 130 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.16626683 |
| 131 | carnitine transmembrane transport (GO:1902603) | 2.15532531 |
| 132 | lymphangiogenesis (GO:0001946) | 2.15477803 |
| 133 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.14561031 |
| 134 | midgut development (GO:0007494) | 2.14450041 |
| 135 | nucleobase catabolic process (GO:0046113) | 2.13573445 |
| 136 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.13157294 |
| 137 | phosphate ion transmembrane transport (GO:0035435) | 2.12500400 |
| 138 | actin-mediated cell contraction (GO:0070252) | 2.12315631 |
| 139 | axon extension (GO:0048675) | 2.11733965 |
| 140 | gap junction assembly (GO:0016264) | 2.10915132 |
| 141 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.10109602 |
| 142 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.08406267 |
| 143 | gastrulation with mouth forming second (GO:0001702) | 2.07845054 |
| 144 | regulation of cardioblast differentiation (GO:0051890) | 2.07506384 |
| 145 | amino-acid betaine transport (GO:0015838) | 2.05531288 |
| 146 | carnitine transport (GO:0015879) | 2.05531288 |
| 147 | morphogenesis of an epithelial sheet (GO:0002011) | 2.02874622 |
| 148 | neuronal ion channel clustering (GO:0045161) | 2.01311212 |
| 149 | actomyosin structure organization (GO:0031032) | 1.98900545 |
| 150 | establishment of apical/basal cell polarity (GO:0035089) | 1.97340780 |
| 151 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.96402389 |
| 152 | ethanol oxidation (GO:0006069) | 1.96271985 |
| 153 | * neuromuscular junction development (GO:0007528) | 1.96107131 |
| 154 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 1.96105278 |
| 155 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 1.96105278 |
| 156 | actin filament-based movement (GO:0030048) | 1.96064936 |
| 157 | establishment of monopolar cell polarity (GO:0061162) | 1.95774059 |
| 158 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 1.95774059 |
| 159 | cell migration in hindbrain (GO:0021535) | 1.95017076 |
| 160 | quaternary ammonium group transport (GO:0015697) | 1.94855951 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.94768167 |
| 162 | convergent extension (GO:0060026) | 1.93562787 |
| 163 | myotube differentiation (GO:0014902) | 1.93353336 |
| 164 | ventricular cardiac muscle cell action potential (GO:0086005) | 1.92747649 |
| 165 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 1.92021512 |
| 166 | ectodermal placode formation (GO:0060788) | 1.91559934 |
| 167 | artery development (GO:0060840) | 1.91228384 |
| 168 | sarcomere organization (GO:0045214) | 1.90451195 |
| 169 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.90011431 |
| 170 | syncytium formation by plasma membrane fusion (GO:0000768) | 1.89343578 |
| 171 | adult heart development (GO:0007512) | 1.87495818 |
| 172 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.85775430 |
| 173 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 1.85720112 |
| 174 | sodium ion homeostasis (GO:0055078) | 1.85282572 |
| 175 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 1.84154249 |
| 176 | phosphate ion transport (GO:0006817) | 1.82987063 |
| 177 | regulation of hippo signaling (GO:0035330) | 1.82824652 |
| 178 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 1.82472345 |
| 179 | desmosome organization (GO:0002934) | 1.82268352 |
| 180 | dorsal/ventral axis specification (GO:0009950) | 1.82151407 |
| 181 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.81909514 |
| 182 | cell migration involved in sprouting angiogenesis (GO:0002042) | 1.81881462 |
| 183 | lung epithelium development (GO:0060428) | 1.81364359 |
| 184 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.81160270 |
| 185 | ethanol metabolic process (GO:0006067) | 1.81004525 |
| 186 | ephrin receptor signaling pathway (GO:0048013) | 1.79539304 |
| 187 | fatty acid transmembrane transport (GO:1902001) | 1.79390723 |
| 188 | regulation of establishment of planar polarity (GO:0090175) | 1.78953584 |
| 189 | developmental cell growth (GO:0048588) | 1.77813633 |
| 190 | cellular sodium ion homeostasis (GO:0006883) | 1.77582472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44308491 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.44074399 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24857809 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.18466555 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12798579 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09632983 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05773606 |
| 8 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.98591711 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.95819146 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93272702 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93272702 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91460440 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.91168429 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82739205 |
| 15 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82115719 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81780929 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78674684 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.77309425 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.76361476 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72979428 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70684444 |
| 22 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70678991 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68796168 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67243999 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65958125 |
| 26 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.64692804 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62173019 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60748759 |
| 29 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.60291502 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59038223 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58518143 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56461199 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54547846 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54183663 |
| 35 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52678255 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52014152 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51118831 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51113051 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50636363 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48143869 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47692761 |
| 42 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46487738 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46156071 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45950701 |
| 45 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.45578880 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44760909 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42973649 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42519079 |
| 49 | AR_19668381_ChIP-Seq_PC3_Human | 1.41783843 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.40294035 |
| 51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39484072 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36876129 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36375966 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35616630 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35063268 |
| 56 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34996750 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.34068936 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33299869 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33060267 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.32999657 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30866524 |
| 62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.30219389 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29002245 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28955384 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28871334 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28575711 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27422441 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27422171 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26908707 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26388341 |
| 71 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.26005236 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25732123 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25272114 |
| 74 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25115608 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24509453 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24394473 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24134761 |
| 78 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.24057742 |
| 79 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.23251487 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22670972 |
| 81 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.22564286 |
| 82 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.22554931 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.22200520 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22153776 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20765397 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20698113 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20447271 |
| 88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20345210 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20101662 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18875490 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17364422 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15848483 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15547211 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15492169 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14511172 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14204452 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14204452 |
| 98 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13535035 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13385291 |
| 100 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12251524 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10281679 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10043791 |
| 103 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.09797316 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09637919 |
| 105 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.09387502 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08983530 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06950800 |
| 108 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06912814 |
| 109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06746490 |
| 110 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06481625 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06300449 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06057088 |
| 113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05994306 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05534167 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05273032 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04395762 |
| 117 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02860228 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02585144 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02585144 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02417200 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01540813 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01407506 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01012156 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00933624 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00364858 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99303026 |
| 127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99078658 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99078658 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98363017 |
| 130 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98289368 |
| 131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97131005 |
| 132 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95838105 |
| 133 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93280443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.73371385 |
| 2 | MP0003011_delayed_dark_adaptation | 4.47850826 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 4.42788087 |
| 4 | MP0005253_abnormal_eye_physiology | 4.14131871 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.72898882 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.64692161 |
| 7 | MP0005195_abnormal_posterior_eye | 2.40247976 |
| 8 | MP0004270_analgesia | 2.35873677 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.35524785 |
| 10 | MP0003941_abnormal_skin_development | 2.23713310 |
| 11 | MP0002090_abnormal_vision | 2.20524162 |
| 12 | MP0003880_abnormal_central_pattern | 2.17869868 |
| 13 | MP0004272_abnormal_basement_membrane | 2.04504096 |
| 14 | MP0005391_vision/eye_phenotype | 1.99187036 |
| 15 | MP0003787_abnormal_imprinting | 1.99149012 |
| 16 | MP0010030_abnormal_orbit_morphology | 1.97664705 |
| 17 | MP0005423_abnormal_somatic_nervous | 1.95311721 |
| 18 | MP0001324_abnormal_eye_pigmentation | 1.94518989 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 1.92638111 |
| 20 | MP0001299_abnormal_eye_distance/ | 1.89673562 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.89186523 |
| 22 | MP0002638_abnormal_pupillary_reflex | 1.86497910 |
| 23 | MP0001984_abnormal_olfaction | 1.83603463 |
| 24 | MP0002229_neurodegeneration | 1.78004231 |
| 25 | MP0000566_synostosis | 1.77636939 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.73079864 |
| 27 | MP0002822_catalepsy | 1.70632409 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.67781528 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.67335063 |
| 30 | MP0005248_abnormal_Harderian_gland | 1.60718046 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.60036058 |
| 32 | MP0000462_abnormal_digestive_system | 1.58541336 |
| 33 | MP0004233_abnormal_muscle_weight | 1.58169376 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.58109679 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.56945640 |
| 36 | MP0005394_taste/olfaction_phenotype | 1.55689356 |
| 37 | MP0005499_abnormal_olfactory_system | 1.55689356 |
| 38 | MP0001486_abnormal_startle_reflex | 1.51914924 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.51416330 |
| 40 | MP0002752_abnormal_somatic_nervous | 1.51328311 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.50543278 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.48067539 |
| 43 | MP0003879_abnormal_hair_cell | 1.44712479 |
| 44 | MP0005187_abnormal_penis_morphology | 1.43251088 |
| 45 | MP0000778_abnormal_nervous_system | 1.41662617 |
| 46 | MP0004885_abnormal_endolymph | 1.32828647 |
| 47 | MP0008789_abnormal_olfactory_epithelium | 1.32244143 |
| 48 | MP0003890_abnormal_embryonic-extraembry | 1.30675872 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.30344540 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.30035974 |
| 51 | MP0002572_abnormal_emotion/affect_behav | 1.29905154 |
| 52 | MP0002272_abnormal_nervous_system | 1.29715648 |
| 53 | MP0005409_darkened_coat_color | 1.28337088 |
| 54 | MP0000749_muscle_degeneration | 1.27455600 |
| 55 | MP0009745_abnormal_behavioral_response | 1.26987628 |
| 56 | MP0004087_abnormal_muscle_fiber | 1.25653356 |
| 57 | MP0002697_abnormal_eye_size | 1.24896604 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.24595068 |
| 59 | MP0002184_abnormal_innervation | 1.24326432 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.22829431 |
| 61 | MP0008995_early_reproductive_senescence | 1.21877889 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.21105298 |
| 63 | MP0003942_abnormal_urinary_system | 1.20322902 |
| 64 | MP0003045_fibrosis | 1.19679287 |
| 65 | * MP0002064_seizures | 1.16613422 |
| 66 | MP0003937_abnormal_limbs/digits/tail_de | 1.16236309 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.14566546 |
| 68 | MP0002108_abnormal_muscle_morphology | 1.12840244 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.12830707 |
| 70 | MP0000747_muscle_weakness | 1.12508154 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.12282677 |
| 72 | MP0009046_muscle_twitch | 1.11413344 |
| 73 | MP0006292_abnormal_olfactory_placode | 1.11092294 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.10847403 |
| 75 | MP0003115_abnormal_respiratory_system | 1.10698656 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.09389324 |
| 77 | MP0005670_abnormal_white_adipose | 1.08220742 |
| 78 | MP0003868_abnormal_feces_composition | 1.07750221 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.07505316 |
| 80 | MP0003385_abnormal_body_wall | 1.07417054 |
| 81 | MP0004043_abnormal_pH_regulation | 1.07105675 |
| 82 | MP0004215_abnormal_myocardial_fiber | 1.06781648 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.06316017 |
| 84 | MP0002269_muscular_atrophy | 1.03318730 |
| 85 | MP0002233_abnormal_nose_morphology | 1.02208379 |
| 86 | MP0005365_abnormal_bile_salt | 0.99520769 |
| 87 | MP0009672_abnormal_birth_weight | 0.97305789 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.97090386 |
| 89 | MP0006138_congestive_heart_failure | 0.96247395 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.95334545 |
| 91 | MP0005646_abnormal_pituitary_gland | 0.95239173 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 0.95193063 |
| 93 | MP0004085_abnormal_heartbeat | 0.94710081 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.94199880 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.93264076 |
| 96 | MP0001661_extended_life_span | 0.93092635 |
| 97 | MP0001958_emphysema | 0.92823660 |
| 98 | MP0001666_abnormal_nutrient_absorption | 0.92694400 |
| 99 | MP0000751_myopathy | 0.90003300 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.88493821 |
| 101 | MP0005369_muscle_phenotype | 0.87048483 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.86577451 |
| 103 | MP0003283_abnormal_digestive_organ | 0.86213049 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.85904885 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.85626516 |
| 106 | MP0002106_abnormal_muscle_physiology | 0.85192578 |
| 107 | MP0000534_abnormal_ureter_morphology | 0.84989193 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.84468440 |
| 109 | MP0002152_abnormal_brain_morphology | 0.83212891 |
| 110 | MP0003935_abnormal_craniofacial_develop | 0.82910608 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.82028958 |
| 112 | MP0003121_genomic_imprinting | 0.81964284 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.81946065 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.81871987 |
| 115 | MP0009703_decreased_birth_body | 0.81679226 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.80670070 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.80072284 |
| 118 | MP0004924_abnormal_behavior | 0.80072284 |
| 119 | MP0004133_heterotaxia | 0.78442349 |
| 120 | MP0010678_abnormal_skin_adnexa | 0.78296989 |
| 121 | MP0000955_abnormal_spinal_cord | 0.78055739 |
| 122 | MP0000733_abnormal_muscle_development | 0.77792335 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.77577566 |
| 124 | MP0002084_abnormal_developmental_patter | 0.77229785 |
| 125 | MP0003119_abnormal_digestive_system | 0.77008207 |
| 126 | MP0004130_abnormal_muscle_cell | 0.76555799 |
| 127 | MP0003755_abnormal_palate_morphology | 0.76055555 |
| 128 | MP0001188_hyperpigmentation | 0.75988779 |
| 129 | MP0001849_ear_inflammation | 0.75793363 |
| 130 | MP0002089_abnormal_postnatal_growth/wei | 0.75618756 |
| 131 | MP0002249_abnormal_larynx_morphology | 0.75384220 |
| 132 | MP0003122_maternal_imprinting | 0.75378122 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.74776812 |
| 134 | MP0002092_abnormal_eye_morphology | 0.74309726 |
| 135 | MP0000428_abnormal_craniofacial_morphol | 0.72058727 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.71540105 |
| 137 | MP0003878_abnormal_ear_physiology | 0.71540105 |
| 138 | MP0000432_abnormal_head_morphology | 0.71453939 |
| 139 | MP0001970_abnormal_pain_threshold | 0.71286395 |
| 140 | MP0003861_abnormal_nervous_system | 0.71280684 |
| 141 | MP0000579_abnormal_nail_morphology | 0.70815165 |
| 142 | MP0004858_abnormal_nervous_system | 0.70370992 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.69433384 |
| 144 | MP0003634_abnormal_glial_cell | 0.69115551 |
| 145 | MP0001293_anophthalmia | 0.68561383 |
| 146 | MP0005623_abnormal_meninges_morphology | 0.68061867 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.66814853 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.65253199 |
| 149 | MP0002736_abnormal_nociception_after | 0.64458194 |
| 150 | MP0003698_abnormal_male_reproductive | 0.63559213 |
| 151 | MP0001501_abnormal_sleep_pattern | 0.63247640 |
| 152 | MP0008569_lethality_at_weaning | 0.62543629 |
| 153 | MP0002733_abnormal_thermal_nociception | 0.61726251 |
| 154 | MP0006276_abnormal_autonomic_nervous | 0.61374983 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.60992679 |
| 156 | MP0002735_abnormal_chemical_nociception | 0.60739358 |
| 157 | MP0000537_abnormal_urethra_morphology | 0.60665709 |
| 158 | MP0002102_abnormal_ear_morphology | 0.60518073 |
| 159 | MP0001177_atelectasis | 0.60473856 |
| 160 | MP0004742_abnormal_vestibular_system | 0.60252476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 9.76731558 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 7.78991593 |
| 3 | Central scotoma (HP:0000603) | 6.92867938 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.47531965 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 6.34043926 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.31484179 |
| 7 | Scotoma (HP:0000575) | 5.73451803 |
| 8 | Pendular nystagmus (HP:0012043) | 5.49782352 |
| 9 | Chorioretinal atrophy (HP:0000533) | 5.40128430 |
| 10 | Dyschromatopsia (HP:0007641) | 5.22587340 |
| 11 | Pigmentary retinal degeneration (HP:0001146) | 4.88389036 |
| 12 | Decreased central vision (HP:0007663) | 4.84977426 |
| 13 | Attenuation of retinal blood vessels (HP:0007843) | 4.68333840 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 4.63465890 |
| 15 | Type II diabetes mellitus (HP:0005978) | 4.05248603 |
| 16 | Severe visual impairment (HP:0001141) | 4.03725031 |
| 17 | Cone-rod dystrophy (HP:0000548) | 3.86941136 |
| 18 | Posterior subcapsular cataract (HP:0007787) | 3.76359042 |
| 19 | Macular degeneration (HP:0000608) | 3.53719296 |
| 20 | Photophobia (HP:0000613) | 3.52585353 |
| 21 | Keratoconus (HP:0000563) | 3.52045722 |
| 22 | Increased corneal curvature (HP:0100692) | 3.52045722 |
| 23 | Congenital sensorineural hearing impairment (HP:0008527) | 2.96320500 |
| 24 | Vitreoretinal degeneration (HP:0000655) | 2.94447290 |
| 25 | Choroideremia (HP:0001139) | 2.92823913 |
| 26 | Subcapsular cataract (HP:0000523) | 2.92756211 |
| 27 | Retinitis pigmentosa (HP:0000510) | 2.89206329 |
| 28 | Constricted visual fields (HP:0001133) | 2.86383465 |
| 29 | Epileptic encephalopathy (HP:0200134) | 2.84829937 |
| 30 | Muscle fiber inclusion bodies (HP:0100299) | 2.69934695 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.67469100 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.60572721 |
| 33 | Exercise-induced myalgia (HP:0003738) | 2.56958960 |
| 34 | Nemaline bodies (HP:0003798) | 2.47826328 |
| 35 | Febrile seizures (HP:0002373) | 2.46142031 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 2.37249838 |
| 37 | Hyperkalemia (HP:0002153) | 2.31675939 |
| 38 | Aplasia involving bones of the extremities (HP:0009825) | 2.30630604 |
| 39 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.30630604 |
| 40 | Aplasia of the phalanges of the hand (HP:0009802) | 2.30630604 |
| 41 | Hepatoblastoma (HP:0002884) | 2.27159187 |
| 42 | Focal motor seizures (HP:0011153) | 2.24979716 |
| 43 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.24235980 |
| 44 | Bronchomalacia (HP:0002780) | 2.23608161 |
| 45 | Abnormality of the calf musculature (HP:0001430) | 2.22503576 |
| 46 | Rimmed vacuoles (HP:0003805) | 2.21902322 |
| 47 | Bundle branch block (HP:0011710) | 2.14147419 |
| 48 | Progressive visual loss (HP:0000529) | 2.13339818 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10800985 |
| 50 | Calf muscle hypertrophy (HP:0008981) | 2.10709344 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 2.09813528 |
| 52 | Gait imbalance (HP:0002141) | 2.08419313 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.03497429 |
| 54 | Papillary thyroid carcinoma (HP:0002895) | 2.03188962 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.02888495 |
| 56 | Prolonged QT interval (HP:0001657) | 2.02475509 |
| 57 | Genetic anticipation (HP:0003743) | 2.02001812 |
| 58 | Hyperactive renin-angiotensin system (HP:0000841) | 2.01552106 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.00124147 |
| 60 | Congenital primary aphakia (HP:0007707) | 1.98997682 |
| 61 | Retinal atrophy (HP:0001105) | 1.96998207 |
| 62 | Cortical dysplasia (HP:0002539) | 1.96176854 |
| 63 | Focal seizures (HP:0007359) | 1.93726510 |
| 64 | Shallow orbits (HP:0000586) | 1.90867330 |
| 65 | Cutaneous finger syndactyly (HP:0010554) | 1.87277688 |
| 66 | Broad metatarsal (HP:0001783) | 1.86062628 |
| 67 | Pancreatic fibrosis (HP:0100732) | 1.84462875 |
| 68 | Syncope (HP:0001279) | 1.81661404 |
| 69 | Overgrowth (HP:0001548) | 1.81602814 |
| 70 | Visual hallucinations (HP:0002367) | 1.81281371 |
| 71 | Turricephaly (HP:0000262) | 1.80986960 |
| 72 | Hemangiomatosis (HP:0007461) | 1.80481342 |
| 73 | Spinal rigidity (HP:0003306) | 1.80075513 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 1.79869066 |
| 75 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78382570 |
| 76 | Drooling (HP:0002307) | 1.77379726 |
| 77 | Excessive salivation (HP:0003781) | 1.77379726 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 1.76684316 |
| 79 | Cystic liver disease (HP:0006706) | 1.74924666 |
| 80 | Male infertility (HP:0003251) | 1.74792359 |
| 81 | Submucous cleft hard palate (HP:0000176) | 1.74432192 |
| 82 | Difficulty running (HP:0009046) | 1.74366636 |
| 83 | Absence seizures (HP:0002121) | 1.74245482 |
| 84 | Cutaneous syndactyly (HP:0012725) | 1.73955277 |
| 85 | Visceral angiomatosis (HP:0100761) | 1.70680740 |
| 86 | Lymphangioma (HP:0100764) | 1.70525179 |
| 87 | Macroorchidism (HP:0000053) | 1.70487978 |
| 88 | Intrahepatic cholestasis (HP:0001406) | 1.70153176 |
| 89 | Neonatal short-limb short stature (HP:0008921) | 1.70034172 |
| 90 | Wide nasal bridge (HP:0000431) | 1.69401162 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 1.69306706 |
| 92 | Abnormality of permanent molar morphology (HP:0011071) | 1.65856829 |
| 93 | Abnormality of the dental root (HP:0006486) | 1.65856829 |
| 94 | Taurodontia (HP:0000679) | 1.65856829 |
| 95 | Hypoventilation (HP:0002791) | 1.65852380 |
| 96 | Genital tract atresia (HP:0001827) | 1.65246792 |
| 97 | Amblyopia (HP:0000646) | 1.64838526 |
| 98 | Hammertoe (HP:0001765) | 1.63133449 |
| 99 | Dysdiadochokinesis (HP:0002075) | 1.62023160 |
| 100 | Poor coordination (HP:0002370) | 1.61959348 |
| 101 | Elfin facies (HP:0004428) | 1.61880463 |
| 102 | Abnormality of the ischium (HP:0003174) | 1.61616401 |
| 103 | Abnormality of the dental pulp (HP:0006479) | 1.61531910 |
| 104 | Polar cataract (HP:0010696) | 1.61462573 |
| 105 | Choanal stenosis (HP:0000452) | 1.61430694 |
| 106 | Vaginal atresia (HP:0000148) | 1.59579953 |
| 107 | Limited hip movement (HP:0008800) | 1.58960124 |
| 108 | Abnormality of molar morphology (HP:0011070) | 1.58751541 |
| 109 | Abnormality of molar (HP:0011077) | 1.58751541 |
| 110 | Hyperventilation (HP:0002883) | 1.58472585 |
| 111 | Epileptiform EEG discharges (HP:0011182) | 1.57736631 |
| 112 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.57724775 |
| 113 | Truncal ataxia (HP:0002078) | 1.57489491 |
| 114 | Distal arthrogryposis (HP:0005684) | 1.57460273 |
| 115 | Male pseudohermaphroditism (HP:0000037) | 1.57288065 |
| 116 | Gaze-evoked nystagmus (HP:0000640) | 1.56874696 |
| 117 | Coronal craniosynostosis (HP:0004440) | 1.56658307 |
| 118 | Atonic seizures (HP:0010819) | 1.55645926 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.55352973 |
| 120 | Sudden death (HP:0001699) | 1.54241612 |
| 121 | Protrusio acetabuli (HP:0003179) | 1.54127626 |
| 122 | Frequent falls (HP:0002359) | 1.54036611 |
| 123 | Severe Myopia (HP:0011003) | 1.52799461 |
| 124 | Limb-girdle muscle atrophy (HP:0003797) | 1.52749118 |
| 125 | Renovascular hypertension (HP:0100817) | 1.52199000 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.52095047 |
| 127 | Flat acetabular roof (HP:0003180) | 1.50808199 |
| 128 | Generalized tonic-clonic seizures (HP:0002069) | 1.50668479 |
| 129 | Advanced eruption of teeth (HP:0006288) | 1.50456865 |
| 130 | Mixed hearing impairment (HP:0000410) | 1.49956892 |
| 131 | Midline defect of the nose (HP:0004122) | 1.49811002 |
| 132 | Increased variability in muscle fiber diameter (HP:0003557) | 1.49297234 |
| 133 | Broad-based gait (HP:0002136) | 1.49011804 |
| 134 | Lower limb amyotrophy (HP:0007210) | 1.48416694 |
| 135 | Dysmetric saccades (HP:0000641) | 1.47716840 |
| 136 | Cervical subluxation (HP:0003308) | 1.46817430 |
| 137 | Abnormal pancreas size (HP:0012094) | 1.46797936 |
| 138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.46602638 |
| 139 | True hermaphroditism (HP:0010459) | 1.46535249 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.46534985 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.46534985 |
| 142 | Abnormality of dentin (HP:0010299) | 1.45925751 |
| 143 | Bifid scrotum (HP:0000048) | 1.45766405 |
| 144 | Back pain (HP:0003418) | 1.45730389 |
| 145 | Insomnia (HP:0100785) | 1.45430156 |
| 146 | Ependymoma (HP:0002888) | 1.45293788 |
| 147 | Germ cell neoplasia (HP:0100728) | 1.44975957 |
| 148 | Skin nodule (HP:0200036) | 1.44380243 |
| 149 | Hypoalphalipoproteinemia (HP:0003233) | 1.44105805 |
| 150 | Abnormality of the astrocytes (HP:0100707) | 1.43858901 |
| 151 | Astrocytoma (HP:0009592) | 1.43858901 |
| 152 | Late onset (HP:0003584) | 1.43731997 |
| 153 | Exotropia (HP:0000577) | 1.43717467 |
| 154 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.43515966 |
| 155 | Abnormal EKG (HP:0003115) | 1.43500557 |
| 156 | Increased connective tissue (HP:0009025) | 1.42189261 |
| 157 | Abnormal atrioventricular conduction (HP:0005150) | 1.41785502 |
| 158 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.41737074 |
| 159 | EMG: myopathic abnormalities (HP:0003458) | 1.41061526 |
| 160 | Alacrima (HP:0000522) | 1.40914212 |
| 161 | Heart block (HP:0012722) | 1.40672000 |
| 162 | Decreased circulating renin level (HP:0003351) | 1.40572032 |
| 163 | Myopathic facies (HP:0002058) | 1.40537885 |
| 164 | Precocious puberty (HP:0000826) | 1.40197639 |
| 165 | Scapular winging (HP:0003691) | 1.39940489 |
| 166 | Abnormality of pain sensation (HP:0010832) | 1.39731916 |
| 167 | Impaired pain sensation (HP:0007328) | 1.39731916 |
| 168 | Chronic bronchitis (HP:0004469) | 1.38356591 |
| 169 | Wrist flexion contracture (HP:0001239) | 1.38203244 |
| 170 | Hand muscle atrophy (HP:0009130) | 1.38049066 |
| 171 | Distal lower limb amyotrophy (HP:0008944) | 1.37942653 |
| 172 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.37839981 |
| 173 | Spastic diplegia (HP:0001264) | 1.37417297 |
| 174 | Dialeptic seizures (HP:0011146) | 1.37207462 |
| 175 | Complement deficiency (HP:0004431) | 1.37067038 |
| 176 | Vertebral arch anomaly (HP:0008438) | 1.36310982 |
| 177 | Muscle fiber splitting (HP:0003555) | 1.35768704 |
| 178 | Arterial tortuosity (HP:0005116) | 1.35714971 |
| 179 | Ankle clonus (HP:0011448) | 1.35598318 |
| 180 | Thyroid carcinoma (HP:0002890) | 1.34747945 |
| 181 | Nephronophthisis (HP:0000090) | 1.34704165 |
| 182 | Volvulus (HP:0002580) | 1.34480522 |
| 183 | Depression (HP:0000716) | 1.34012381 |
| 184 | Absent speech (HP:0001344) | 1.32715917 |
| 185 | Chronic hepatic failure (HP:0100626) | 1.32247757 |
| 186 | Obsessive-compulsive behavior (HP:0000722) | 1.31152969 |
| 187 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.30615807 |
| 188 | Mask-like facies (HP:0000298) | 1.29461851 |
| 189 | Myokymia (HP:0002411) | 1.29379620 |
| 190 | Abnormality of midbrain morphology (HP:0002418) | 1.28906501 |
| 191 | Molar tooth sign on MRI (HP:0002419) | 1.28906501 |
| 192 | Neoplasm of the heart (HP:0100544) | 1.28086399 |
| 193 | Testicular neoplasm (HP:0010788) | 1.28002038 |
| 194 | Absent eyebrow (HP:0002223) | 1.27364588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 3.28783795 |
| 2 | OBSCN | 2.98912909 |
| 3 | GRK1 | 2.85418434 |
| 4 | LATS1 | 2.81251934 |
| 5 | AKT3 | 2.75370672 |
| 6 | EEF2K | 2.42851369 |
| 7 | INSRR | 2.33528177 |
| 8 | PRKD3 | 2.30340657 |
| 9 | NTRK3 | 2.21481802 |
| 10 | EPHA4 | 2.21253443 |
| 11 | MARK1 | 2.14712332 |
| 12 | DAPK2 | 2.11740397 |
| 13 | TTN | 1.99812161 |
| 14 | MAP2K7 | 1.97377414 |
| 15 | STK38 | 1.93353391 |
| 16 | MAP3K9 | 1.91343502 |
| 17 | FRK | 1.85190194 |
| 18 | CAMK1G | 1.85010273 |
| 19 | CASK | 1.79730031 |
| 20 | MET | 1.68846671 |
| 21 | PAK6 | 1.61668157 |
| 22 | BRD4 | 1.61173624 |
| 23 | EPHA3 | 1.53304901 |
| 24 | CDK12 | 1.53085046 |
| 25 | RIPK1 | 1.51495107 |
| 26 | TIE1 | 1.50350051 |
| 27 | EPHA2 | 1.43332515 |
| 28 | LMTK2 | 1.40282566 |
| 29 | MAP2K4 | 1.39972181 |
| 30 | CAMK1D | 1.39946828 |
| 31 | MAP3K2 | 1.39686053 |
| 32 | MST1R | 1.36298744 |
| 33 | SGK2 | 1.33068197 |
| 34 | NUAK1 | 1.26926033 |
| 35 | SGK223 | 1.25082037 |
| 36 | SGK494 | 1.25082037 |
| 37 | FER | 1.21785964 |
| 38 | DMPK | 1.17690851 |
| 39 | TRIB3 | 1.17613800 |
| 40 | MINK1 | 1.16391743 |
| 41 | PNCK | 1.15754865 |
| 42 | TYRO3 | 1.15540707 |
| 43 | STK38L | 1.10640451 |
| 44 | MAP3K6 | 1.09597327 |
| 45 | FGFR4 | 1.09493787 |
| 46 | CDC42BPA | 1.08859513 |
| 47 | KSR1 | 1.08385385 |
| 48 | PLK2 | 1.08121918 |
| 49 | ICK | 1.05611919 |
| 50 | TNIK | 1.05327514 |
| 51 | SGK3 | 1.05155193 |
| 52 | PTK2 | 1.03886665 |
| 53 | WNK3 | 1.01799527 |
| 54 | DYRK1A | 1.00774283 |
| 55 | PKN2 | 1.00388379 |
| 56 | PINK1 | 0.98524905 |
| 57 | MAPK13 | 0.95116919 |
| 58 | PAK3 | 0.94931587 |
| 59 | NTRK2 | 0.94155745 |
| 60 | WNK1 | 0.92363054 |
| 61 | TAOK3 | 0.92271482 |
| 62 | KSR2 | 0.91603993 |
| 63 | CDK5 | 0.91082091 |
| 64 | PHKG2 | 0.89685697 |
| 65 | PHKG1 | 0.89685697 |
| 66 | PRKAA2 | 0.87285518 |
| 67 | RET | 0.84689980 |
| 68 | PDGFRA | 0.80612701 |
| 69 | CAMKK1 | 0.78285101 |
| 70 | ERBB3 | 0.77941299 |
| 71 | SGK1 | 0.76090491 |
| 72 | ERBB2 | 0.76052385 |
| 73 | LATS2 | 0.76048445 |
| 74 | NTRK1 | 0.75446712 |
| 75 | DAPK1 | 0.75332523 |
| 76 | FGFR2 | 0.75264152 |
| 77 | DDR2 | 0.74911972 |
| 78 | PRKAA1 | 0.74785196 |
| 79 | PDGFRB | 0.74755222 |
| 80 | MYLK | 0.70221217 |
| 81 | MAPK15 | 0.69055489 |
| 82 | PAK2 | 0.68715805 |
| 83 | PRKCH | 0.68417891 |
| 84 | HIPK2 | 0.68032951 |
| 85 | FGFR3 | 0.65981895 |
| 86 | CDK3 | 0.64700839 |
| 87 | PTK2B | 0.64563576 |
| 88 | CSNK1G1 | 0.64526693 |
| 89 | CDK9 | 0.64404763 |
| 90 | WNK4 | 0.64060442 |
| 91 | EPHB2 | 0.63113069 |
| 92 | CAMK1 | 0.62907670 |
| 93 | CAMK2A | 0.60683280 |
| 94 | CSNK1G2 | 0.59280205 |
| 95 | PRKCZ | 0.57847456 |
| 96 | STK39 | 0.57593863 |
| 97 | DYRK1B | 0.56888707 |
| 98 | CAMK2D | 0.56430203 |
| 99 | MARK2 | 0.56361599 |
| 100 | SIK2 | 0.55490152 |
| 101 | RPS6KA3 | 0.55195286 |
| 102 | STK11 | 0.54481716 |
| 103 | CSNK1A1L | 0.53463710 |
| 104 | PRPF4B | 0.53335254 |
| 105 | ADRBK1 | 0.53221107 |
| 106 | CAMK4 | 0.52325766 |
| 107 | MAP3K7 | 0.51524966 |
| 108 | STK3 | 0.51136200 |
| 109 | DYRK2 | 0.49696926 |
| 110 | * GSK3B | 0.49092217 |
| 111 | ERBB4 | 0.49001484 |
| 112 | PBK | 0.47232803 |
| 113 | FGFR1 | 0.46829734 |
| 114 | RPS6KA2 | 0.46725713 |
| 115 | PIK3CA | 0.46473735 |
| 116 | AKT2 | 0.46399624 |
| 117 | CSNK1D | 0.45845164 |
| 118 | MAPK10 | 0.45548410 |
| 119 | PRKCE | 0.45307115 |
| 120 | PRKCB | 0.45118634 |
| 121 | MTOR | 0.44115831 |
| 122 | TTK | 0.43960645 |
| 123 | ROCK2 | 0.42885376 |
| 124 | NEK1 | 0.42838421 |
| 125 | CSNK1E | 0.42087413 |
| 126 | ROCK1 | 0.41990564 |
| 127 | PRKCG | 0.41854757 |
| 128 | PAK4 | 0.41842330 |
| 129 | SCYL2 | 0.40913325 |
| 130 | RPS6KB1 | 0.40323951 |
| 131 | CAMK2B | 0.40170193 |
| 132 | PDK2 | 0.39936691 |
| 133 | BCR | 0.39580753 |
| 134 | PRKG2 | 0.37201951 |
| 135 | PRKDC | 0.36836082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 7.51612001 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26896756 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.20809921 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.09345783 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.08986082 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02417155 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.00646947 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93733640 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.74954925 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72922477 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65616777 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.64607650 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63284906 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61775610 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.56373008 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56031114 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.55406832 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53640819 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.52409902 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.52092401 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49816210 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49149707 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46955264 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42005828 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35014180 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.34019873 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.32997394 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32842685 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32238421 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30791080 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27216593 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27048313 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25112654 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24479982 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22267521 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.21809686 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21352025 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18970438 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16079249 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15795899 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15576351 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15532862 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15156282 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14010335 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13198869 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12340528 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09124732 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07669221 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03561263 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03466208 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03105673 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01963740 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01823842 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01238180 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00957109 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.99042750 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98346329 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97509463 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97129432 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97104663 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96739309 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96340821 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.96261565 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95237801 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94645100 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93177044 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92694189 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92407745 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92016987 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91595822 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91180993 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90602966 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90445873 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90206444 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89829085 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.89469214 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88991288 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87912268 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87851158 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87703386 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87153833 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87000647 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86797108 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.86697786 |
| 85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85476532 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85358733 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84664556 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84462929 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83849125 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.81916574 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81014389 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.80745408 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77840524 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77832138 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76861637 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74012320 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73867826 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73609879 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73271126 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.73201433 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72629686 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71870773 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70982382 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70068694 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68467819 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67982760 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67761217 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67666240 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.66711747 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66343881 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.63120859 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62773696 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62511445 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62390532 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60319692 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60260060 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59629592 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58431641 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58225441 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.58164373 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58145294 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57631466 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56228931 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54687738 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54388832 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53356579 |
| 127 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52453618 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50711995 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50147959 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49367473 |
| 131 | Focal adhesion_Homo sapiens_hsa04510 | 0.48903809 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48276018 |
| 133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47531226 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47503683 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46060555 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45904220 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45625627 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43127850 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43000263 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.42796229 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42524803 |
| 142 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42358458 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40471992 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39778870 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38978249 |
| 146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38369902 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37936396 |

